Sandbox/thy02: Difference between revisions
< Sandbox
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 18: | Line 18: | ||
</font> | </font> | ||
</div> | </div> | ||
<table class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table-resectable" style="background: #FFFFFF; float: left; cellpadding=0; cellspacing= 0; width: 400px;" cellspacing="0" cellpadding="0" border="0"> | <table class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table-resectable" style="background: #FFFFFF; float: left; cellpadding=0; cellspacing= 0; width: 400px;" cellspacing="0" cellpadding="0" border="0"> | ||
| Line 36: | Line 32: | ||
<tr align="center"><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td colspan="6" rowspan="2" style="border: 2px solid black; padding: 0.2em; background: WhiteSmoke;;">Surveillance for recurrence with CT <br /> every 6 month for 2 y, then annually every 5 y for thymic carcinoma <br /> and 10 y for thymoma</td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td></tr><tr align="center"></tr> | <tr align="center"><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td colspan="6" rowspan="2" style="border: 2px solid black; padding: 0.2em; background: WhiteSmoke;;">Surveillance for recurrence with CT <br /> every 6 month for 2 y, then annually every 5 y for thymic carcinoma <br /> and 10 y for thymoma</td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td><td rowspan="2" colspan="2"><div style="width:2em;height:2em"><span style="font:1px/1px serif"> </span></div></td></tr><tr align="center"></tr> | ||
</table> | </table> | ||
<table class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table-Unresectable" style="background: #FFFFFF; float: left; cellpadding=0; cellspacing= 0; width: 400px;" cellspacing="0" cellpadding="0" border="0"> | <table class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table-Unresectable" style="background: #FFFFFF; float: left; cellpadding=0; cellspacing= 0; width: 400px;" cellspacing="0" cellpadding="0" border="0"> | ||
Revision as of 21:47, 27 February 2014
Treatment of Thymoma and Thymic Carcinoma
Thymic Tumor
▸ Resectable
▸ Unresectable
Pathology Evaluation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| R0 Resection | R1 Resection | R2 Resection | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thymoma, no capsular invasion or thymic carcinoma, stage I | Thymoma or thymic carcinoma, capsular invasion present, stages II-IV | Thymoma | Thymic carcinoma | Thymoma | Thymic carcinoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Postoperative RT | Postoperative RT | Postoperative RT + Chemotherapy | RT ± Chemotherapy | RT + Chemotherapy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Surveillance for recurrence with CT every 6 month for 2 y, then annually every 5 y for thymic carcinoma and 10 y for thymoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thymoma or Thymic Carcinoma | |||||||||||||||||||||||||||||||||||||||
Locally Advanced | Solitary Metastasis | Distant metastasis | |||||||||||||||||||||||||||||||||||||
Surgery | |||||||||||||||||||||||||||||||||||||||
Re-evaluate for surgery | Chemotherapy or RT | ||||||||||||||||||||||||||||||||||||||
Resectable | Unresectable | ||||||||||||||||||||||||||||||||||||||
Surgery ± Postoperative RT | |||||||||||||||||||||||||||||||||||||||